|
Oxford Nanopore Technologies PLC shares surged on Friday as it set out upbeat guidance for the full-year. The Oxford-based specialist in DNA and RNA sequencing technologies said 2025 constant currency revenue growth is to be at the top end of its stated 20% to 23% range. ‘All other financial metrics tracking in line with expectations,’ it added, in a brief update on Friday. Revenue in 2024 amounted to £183.2 million, rising 8.0% on a reported basis and 11% at constant currency. Shares in the company rose 6.7% to 142.60 pence each in London on Friday morning. Oxford Nanopore in August announced Chief Executive Officer Gordon Sanghera will leave the company at the end of 2026. With a CEO succession process ‘actively underway’, the firm has postponed an investor event scheduled for this time next week, ‘pending appointment of the new CEO’. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
